The nation of Zimbabwe has rejected a significant American healthcare agreement worth $367m (£272m) spanning five years over the United States' request for sensitive information.
The decision came to light following a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesman later explained that the US was requesting genetic material for scientific study and profit but refused to guarantee the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for continued negotiations to find a agreement suitable to both sides so the country's vital HIV treatment initiative can continue.
Wider Context
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a court halted a related deal with the US after concerns were filed about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had managed assistance for the American government, but Trump argued its spending was "wasteful" and his government was seeking direct bilateral deals to enhance openness and accountability.
As per statements, Sixteen nations in Africa have to date agreed to these new health pacts, representing over $18.3bn of fresh investment.
Specifics of the Rejected Deal
The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, with no equivalent assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Put simply, our nation would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our citizens if a new pandemic arise."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining structures previously set up through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to manage potential pandemics.
"This mechanism is intended to guarantee that when a country provides its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to create them."
These objections regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome ongoing dialogue with our American counterparts on how future co-operation might be designed in a way that honours the independence and dignity of each country."
Health Experts Reaction
Medical experts said it acknowledged the official position, but recommended that negotiations must proceed given that a large portion of the nation's HIV programmes relied on international support.
"Where technical issues exist, such as those relating to data governance or implementation frameworks, these can often be resolved via detailed discussion and mutually agreed protections," it added.
This impasse underscores the continuing debate between accepting much-needed foreign assistance and safeguarding local interests in an increasingly interconnected world.